Smspharma
Live Price
Recent news and updates for SMSPHARMA will appear here soon.
"Balanced market signals for SMSPHARMA. The stock is currently consolidating with neutral technical indicators and fundamental alignment between current healthcare growth rates and prevailing valuation metrics."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
As of the latest market session, Smspharma (SMSPHARMA) is trading at ₹402.95, representing a move of -1.76% from the previous close.
Smspharma is listed and traded under the ticker symbol SMSPHARMA on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Smspharma's stock price moved by -1.76%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 65% bullish probability for SMSPHARMA stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Smspharma shares reached a high of ₹482 and hit a low of ₹242.25.
SMSPHARMA exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 8,02,581 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Smspharma has a market capitalization of ₹3773.71 Cr, designating its size class inside the Healthcare sector.
Smspharma has a current dividend yield of 10.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Smspharma's trailing Price-to-Earnings (P/E) ratio is 36.40. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Smspharma (SMSPHARMA) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Smspharma's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore SMSPHARMA's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for SMSPHARMA are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Smspharma operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.